Which of the following is a treatment for Pseudodementia?

Pseudodementia, often caused by depression in older adults, presents with cognitive impairment resembling dementia but is primarily linked to mood disorders rather than irreversible brain changes. Treatment for pseudodementia focuses on addressing the underlying depressive symptoms.

SSRIs, or selective serotonin reuptake inhibitors, are commonly prescribed as they effectively alleviate symptoms of depression, which, in turn, can lead to an improvement in cognitive function. As mood improves, the cognitive issues associated with pseudodementia often resolve, thereby differentiating it from true dementia, which does not show such reversibility.

While psychotherapy is also beneficial, particularly in terms of supporting the patient, SSRIs directly target the biochemical underpinnings of depression that contribute to cognitive disturbances. Long-term psychotherapy may be beneficial over time, but immediate intervention with SSRIs is often crucial for more rapid symptom relief.

Donepezil is primarily used for Alzheimer’s disease to enhance cholinergic function and is not suitable for treating pseudodementia, emphasizing the distinction between treatment pathways for different types of cognitive impairment.